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Abstract
Pendrin is an anion exchanger whose mutations are known to cause hearing
loss. However, recent data support the linkage between pendrin expression and
airway diseases, such as asthma. To evaluate the role of pendrin in the regula-
tion of the airway surface liquid (ASL) volume and mucin expression, we
investigated the function and expression of pendrin and ion channels and
anion exchangers. Human nasal epithelial cells were cultured from 16 deaf
patients carrying pendrin mutations (DFNB4) and 17 controls. The cells were
treated with IL-13 to induce mucus hypersecretion. Airway surface liquid
thickness was measured and real-time polymerase chain reaction was per-
formed targeting various transporters and MUC5AC. Anion exchanger activity
was measured using a pH-sensitive fluorescent probe. Periodic acid-Schiff
staining was performed on the cultured cells and inferior turbinate tissues. The
ASL layer of the nasal epithelia from DFNB4 subjects was thicker than the con-
trols, and the difference became more prominent following IL-13 stimulation.
There was no difference in anion exchange activity after IL-13 treatment in the
cells from DFNB4 patients, while it increased in the controls. Goblet cell meta-
plasia induced by IL-13 treatment seen in the controls was not observed in the
DFNB4 cells. Furthermore, the periodic acid-Schiff staining-positive area was
lesser in the inferior turbinate tissues from DFNB4 patients that those from
controls. Pendrin plays a critical role in ASL volume regulation and mucin
expression as pendrin-deficient airway epithelial cells are refractory to stimula-
tion with IL-13. Specific blockers targeting pendrin in the airways may there-
fore have therapeutic potential in the treatment of allergic airway diseases.
Introduction
Pendrin, encoded by SLC26A4, is a membrane protein
that exchanges anions such as HCO3
 and I for Cl
(Mount and Romero 2004). The protein is predominantly
expressed in the inner ear, thyroid, and kidney (Scott
et al. 1999; Royaux et al. 2000, 2001; Lacroix et al. 2001).
Pendrin presumably acts as an HCO3
/Cl exchanger in
the inner ear, and mutations cause prelingual hearing loss
with enlarged vestibular aqueducts (DFNB4) (Yang et al.
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2005; Albert et al. 2006; Nakaya et al. 2007). In the thy-
roid, pendrin is essential for I uptake, and defects in this
protein may cause goiter and possibly hypothyroidism.
Goiter combined with hearing loss is known as Pendred
syndrome (Morgans and Trotter 1958; Reardon et al.
1999).
Pendrin is also expressed in the airway epithelia (Kuper-
man et al. 2005; Pedemonte et al. 2007; Nakagami et al.
2008; Nakao et al. 2008; Di Valentin et al. 2009; Nofziger
et al. 2011) and recent data suggest that pendrin expres-
sion is associated with airway diseases. Pendrin expression
is upregulated in airway tissues of patients with asthma
and allergic rhinitis (Kuperman et al. 2005; Lewis et al.
2008; Nakagami et al. 2008; Nakao et al. 2008; Di Valentin
et al. 2009; Izuhara et al. 2009). Moreover, recent study
showed that patients harboring bi-allelic SLC26A4 muta-
tions do not experience asthma (Nakao et al. 2008),
although the prevalence of asthma among these patients is
not significantly lower compared to controls due to the
low numbers of subjects. Animal studies also showed the
role of pendrin in the pathogenesis of asthma. Ovalbu-
min-induced airway hyperresponsiveness and inflamma-
tion are attenuated in pendrin-knockout mice (Nakagami
et al. 2008; Madeo et al. 2009) and the overexpression of
pendrin in airway epithelia of mice resulted in increased
airway hyperresponsiveness (Nakagami et al. 2008). These
findings suggest that pendrin may play an important role
in the development of asthma.
Homeostasis of the volume and composition of the air-
way surface liquid (ASL) is essential for maintaining the
mucociliary clearance system (Tarran et al. 2001; Boucher
2003). Airway surface liquid volume is regulated by the
coordinated interactions of various ion transporters, such
as epithelial sodium channels (ENaC) and cystic fibrosis
transmembrane conductance regulators (CFTR). A recent
report (Nakagami et al. 2008) indicates that pendrin is
involved in ASL volume regulation. ASL thickness was
shown to increase following allergic cytokine, interleukin
(IL)-13, stimulation in the airway epithelia of pendrin-
knockout mice. Another interesting discovery is that pen-
drin may strongly participate in the secretion of airway
mucus. Overexpression of pendrin induces mucus hyper-
secretion in mice, and pendrin has been shown to be a
key modulator of IL-13-induced mucus secretion (Nakao
et al. 2008).
Based on these recent findings, pendrin may be a
potential new drug target for asthma and other inflamma-
tory airway diseases. However, before deciding on the
value of pendrin as a new drug target, further elucidation
of the physiological role of pendrin in human airways is
necessary because the inner ear and the thyroid pheno-
types of pendrin-knockout mice have shown to be differ-
ent from those of patients harboring SLC26A4 mutations
and the physiology underlying ASL homeostasis and
mucus secretion in human airways is quite different from
that in animal models.
In this study, we compare the ASL thickness, mucin
expression, and the response to stimulation with IL-13 in
nasal epithelial cells cultured from patients with SLC26A4
mutations (DFNB4) to those in controls.
Materials and Methods
Subjects and tissue harvesting
This study was approved by the Institutional Review
Board of the Yonsei University Health System. Human
nasal mucosa was obtained from the inferior turbinates of
16 deaf patients harboring bi-allelic SLC26A4 mutations
(DFNB4) during cochlear implantation. Nasal mucosa was
also harvested in 17 controls who underwent septoplasty
for correction of deviated nasal septum. These controls
had no history of allergic rhinitis or chronic sinusitis, and
a genetic study confirmed they did not carry any SLC26A4
mutations. A genetic analysis confirmed the presence of
the bi-allelic SLC26A4 mutation in all 16 deaf patients.
The genotypes of the DFNB4 patients were as follows:
H723R homozygote (n = 6), H723R/IVS7-2A>G (n = 6),
IVS7-2A>G homozygote (n = 2), IVS7-2A>G/M147V
(n = 1) and IVS7-2A>G/I302K (n = 1). H723R, M147V,
I302K mutations produce a misfolding pendrin which
retains within the ER. Slicing mutation, IVS7-2A>G, result
in complete deletion of exon 8. Therefore, all the muta-
tions in this study cannot produce a functioning pendrin.
Table 1 shows the characteristics of the subjects.
Cell culture and IL-13 treatment
Primary cultures of human nasal epithelial (HNE) cells
were obtained as previously described (Yoon et al. 1999).
Passage-2 cells were seeded into a Transwell-Clear culture
insert with a 0.45-lm pore size (Costar Co., Cambridge,
MA) at a density of 2 9 105 cells/cm2. The cells were
maintained in a 1:1 mixture of Dulbecco’s modified
Eagle’s medium (Lonza, Walkersville, MD) and bronchial
epithelial growth medium (Lonza), supplemented with
the following growth factors according to the manufac-
Table 1. Subject characteristics.
N Age Male [no. (%)]
DFNB4* 16 18  12 8 (50)
Control 17 25  7 10 (59)
*Patients with bi-allelic mutation in SLC26A4.
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turer’s instructions: hydrocortisone (0.5 lg/mL), insulin
(5 lg/mL), transferrin (10 lg/mL), epinephrine (0.5 lg/
mL), triiodothyronine (6.5 lg/mL), gentamicin (50 lg/
mL), amphotericin B (50 lg/mL), retinoic acid (15 ng/
mL), bovine pituitary extract (50 lg/mL), bovine serum
albumin (1.5 lg/mL), and epidermal growth factor
(0.5 ng/mL). The cells were maintained submerged for
the first 7 days, after which they were exposed to the api-
cal air interface for the remainder of the culture period.
The cells were used between 14 and 21 days after the
establishment of the air-liquid interface. At all stages of
culture, the cells were maintained at 37°C under 5% CO2
in an air incubator. To stimulate the cells, they were trea-
ted basolaterally with 10 ng/mL of recombinant human
IL-13 (R&D Systems, Minneapolis, MN) for 7 days.
Quantitative real-time PCR
Total RNA was isolated from primary cultures of HNE
cells from five patients harboring bi-allelic SCL26A4
mutations and four controls. RNA was isolated using the
TRIzol reagent (Invitrogen, San Diego, CA) according to
the manufacturer’s protocol. Purified RNA samples were
reverse transcribed with a cDNA Synthesis Kit (Applied
Biosystems, Foster City, CA) according to the manufac-
turer’s instructions. Quantitative Real-time PCR for pen-
drin, epithelial sodium channel (ENaC) a, b, c, CFTR,
ANO-1, Anion exchanger (AE) 2, AE3, AE4 and
SLC26A3, SLC26A6, SLC26A7, SLC26A8, SLC26A9,
SLC26A11, MUC5AC was performed using the 7300
Real-Time PCR System (Applied Biosystems) and the
DyNAmoHSSYBR Green qPCR Kit (Finnzymes, Espoo,
Finland). The primers employed for real time PCR are
listed in Table S1.
Measurement of ASL thickness
The thickness of the ASL was measured in HNE cells
using a modified version of the method described by
Terran et al. (Tarran et al. 2005). Briefly, the cells were
washed, and 20 lL of PBS containing 0.2% (v/v) Texas
Red-dextran (Invitrogen) was added onto the apical cell
surface to label the ASL layer. A 100-lL aliquot of per-
fluorocarbon (Fluorinert FC-770; 3M, St. Paul, MN) was
then added to the apical surface to prevent evaporation
of the ASL. After 12 h, the cultures were transferred to
the stage of an inverted confocal microscope (LSM 700;
Carl Zeiss MicroImaging Inc., Thornwood, NY) and the
height of the ASL was measured at five predetermined
points in the cultures (one central, four circumferential)
via XZ scans. Images were reconstructed three dimen-
sionally and analyzed using Imaris 7.1 software (Bitplane
Co, Zurich, Switzerland).
Short circuit current
Passage-2 primary cultured human nasal epithelial cells
were mounted in Ussing chambers (Physiologic Instru-
ments, San Diego, CA). Amiloride, CFTRinh-172, ATP
were added to the apical solution, and an equal volume
of vehicle was added at the same time to the basolateral
solution. Symmetrical HCO3
-buffered solutions
(120 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgCl2,
1 mmol/L CaCl2, 10 mmol/L D-glucose, 5 mmol/L
HEPES, and 25 mmol/L NaHCO3, pH 7.4) were used.
Cells were bathed for a 10 min stabilization period and
aerated with 95% O2/5% CO2 at 37°C or room tempera-
ture. Short circuit current was measured using an
EVC4000 MultiChannel V/I Clamp (World Precision
Instruments, Sarasota, FL) and recorded using PowerLab/
8sp (AD Instruments, Castle Hill, Australia).
Measurement of anion exchange activity
Measurements of the pHi in the HNE cells were per-
formed with a pH-sensitive fluorescent probe, bis-car-
boxyethyl-carboxyfluorescein (BCECF) (Invitrogen, San
Diego, CA), as described previously (Yoon et al. 2008).
Briefly, the measurements were performed in PBS- or IL-
13-treated cells, in which a cluster of cells showing green
fluorescent protein (GFP) fluorescence was exposed to
BCECF, and the pHi was monitored. After adding
BCECF, the cells were perfused with HCO3
-buffered
solution (120 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 D-glu-
cose, 5 HEPES and 25 NaHCO3 in mmol/L, pH 7.4), and
BCECF fluorescence was recorded at excitation wave-
lengths of 490 nm and 440 nm at a resolution of 2 sec on
a recording setup (Delta Ram; PTI Inc., Birmingham,
NJ). The Cl/HCO3
 exchange activities were estimated
from the initial rate of the pHi increase as a result of Cl

removal in the HCO3
-containing buffer (25 mmol/L
HCO3
 with 5% CO2). The intrinsic buffer capacity (bi)
was measured as described previously (Yoon et al. 2008).
Histology and Periodic acid-Schiff (PAS)
staining
Periodic acid-Schiff (PAS) staining was performed with a
PAS staining kit (Sigma, St. Louis, MO) according to the
manufacturer’s protocol. The harvested nasal mucosa and
HNE cells on the transwell inserts were gently washed
with PBS and fixed with 4% paraformaldehyde. After
deparaffinization and hydration, the slides were immersed
in periodic acid solution for 5 min at room temperature.
After being rinsed in distilled water, the slides were
immersed in Schiff’s reagent for 15 min at room tempera-
ture, and then washed in running tap water for 5 min.
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Slides were counterstained in Hematoxylin Solution for
90 sec and then rinsed in running tap water, dehydrated,
cleared, and permanently mounted. For morphometric
analysis, images of the PAS-stained slides (five different
slides of tissue from each patient) were acquired with a
Leica DM750 LED microscope and PAS-positive cells
were counted.
Statistics
Statistical analysis was performed with SPSS software for
PC, version 19 (SPSS Inc., Chicago, IL). Differences
between groups regarding anion exchange activities and
the rates of pendrin positivity were evaluated via one-way
analysis of variance. A P-value of less than 0.05 was con-
sidered statistically significant.
Results
ASL thickness; DFNB4 patients versus
controls
First, we measured the ASL thickness in HNE cells from
patients harboring SLC26A4 mutations (DFNB4) and
controls. Twelve hours after PBS/Texas Red-dextran load-
ing, the ASL thickness in the DFNB4 patients
(14.1  2.9 lm) was thicker than that in the controls
(8.0  2.1 lm, P < 0.05). The increase in ASL thickness
following IL-13 stimulation was more prominent in
DFNB4 cells (31.3  7.6 lm) than in controls (13.
5  2.8 lm) (Fig. 1).
Molecular and functional expression of Na+
and Cl channels
We compared the mRNA expression patterns of ion
channels involved in ASL volume regulation to rule out
the possibility that the difference in ASL thickness
between the pendrin mutants and controls stemmed from
the differential expression of these channels. The expres-
sion patterns of ENaC subtypes a, b, and c and ANO-1
were similar between DFNB4 patients and controls. How-
ever, CFTR showed lower expression in the DFNB4
patients (0.36  0.25-fold of that in the controls)
(Fig. 2A).
We also measured short circuit current (Isc) in airway
epithelial cells. The amplitude of the amiloride-sensitive
(22.1  7.2 lA/cm2) and ATP-sensitive current
(31.1  6.7 lA/cm2) in DFNB4 cells, which reflects ENaC
and ANO-1 activity, respectively, were not significantly
different between disease controls (28.1  9.4 lA/cm2
and 32.8  7.8 lA/cm2) However, the forskolin-induced
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Figure 1. Airway surface liquid (ASL) thickness in human nasal epithelia from patients harboring SLC26A4 mutations (DFNB4) and controls.
Confocal images (A) and summary of ASL thickness measurements (B) at 12 h after the apical addition of 20 lL of PBS containing Texas Red-
dextran to primary nasal epithelial cultures from DFNB4 patients (n = 5) and controls (n = 4) in the absence or presence of IL-13 (10 ng/mL).
Scale bars, 10 lm. *P < 0.05, **P < 0.01, compared with the controls. Error bars, S.E.
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Figure 2. Expression of epithelial sodium channels (ENaC) and Cl channels (CFTR and ANO-1) in human nasal epithelial cells from patients
harboring SLC26A4 mutations (DFNB4) and controls. (A) The mRNA expression patterns in the cells from patients with DFNB4 (n = 3) are
similar to those in controls (n = 3), except for CFTR, which shows low levels of expression in the epithelia from DFNB4 patients. *indicates
P < 0.05, compared to controls. (B) Amiloride-sensitive and ATP-induced short circuit current is similar in the cells from patients with DFNB4
(n = 4) to those in the controls (n = 3). Forskolin–induced current is smaller in the DNFB cells than those in the control cells.
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Figure 3. Changes in ion channel and pendrin expression in response to IL-13 treatment (10 ng/ml). In both the control (n = 3) and SLC26A4
mutant (DFNB4) (n = 3) nasal epithelia, ENaCb and c expression are suppressed, and ANO-1 expression is greatly increased (by more than 50
fold) following IL-13 treatment. In the control epithelia, pendrin is also upregulated (approximately 100 fold) following IL-13 treatment.
*indicates P < 0.05.
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current, which indicates CFTR activity, was smaller in
DFNB cells (29.4  9.2 lA/cm2)than in disease controls
(42.1  6.6 lA/cm2) (Fig. 2B).
Changes of channel and pendrin expressions
in response to IL-13
When the HNE cells from controls were treated with IL-
13, ENaC subtypes b and c were downregulated, whereas
ANO-1 (49  18 fold of PBS) was upregulated. As previ-
ously reported, pendrin expression was also greatly
increased by 104  27 fold following treatment with IL-
13. The response of the pendrin-deficient epithelial cells
to IL-13 treatment was similar to the response in the con-
trols: ENaC subtypes b and c were downregulated, and
ANO-1 was upregulated (61  26 fold) (Fig. 3).
Anion exchanger expression and activity
In addition to SLC26A4, various anion exchangers,
including AE2, AE3, AE4, SLC26A3, SLC26A6, SLC26A7,
SLC26A8, SLC26A9, and SLC26A11, were found to be
expressed in the HNE cells of the controls. When the cells
were treated with IL-13, SLC26A3 was upregulated (by
8.2  5.4 fold compared to PBS treatment) along with
SLC26A4. The other anion exchangers did not respond to
IL-13 stimulation (Fig. 4). We also examined anion chan-
nel activity by measuring the Cl/HCO3
 exchange ratio.
The anion exchange activity in epithelia from the patients
harboring SLC26A4 mutations (DFNB4) (0.12  0.07
Figure 4. Anion exchanger expression in cultured human nasal
epithelia from controls. Along with pendrin, various anion
exchangers (AE2, AE3 and AE4) and SLC26A family transporters
(SLC26A3, SLC26A6, SLC26A7, SLC26A8, SLC26A9, and
SLC26A11) are expressed in nasal epithelia from controls (n = 5).
Only SLC26A3 is increased by IL-13 (10 ng/mL). *indicates P < 0.05
compared with the PBS-treated cells.
A B
Figure 5. Anion exchange activity in human nasal epithelia cultured from patients with SLC26A4 mutations (DFNB4) and controls. (A)
Representative tracings of anion exchange activity. (B) Measurements of anion exchange activity showing significantly increased activity
following IL-13 treatment (10 ng/mL) in the controls (n = 4) but not in epithelia from patients harboring SLC26A4 mutations (DFNB4, n = 5).
*indicates P < 0.05 compared with the PBS-treated cells.
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DpH/min) was not different from that in the controls
(0.15  0.06 DpH/min) under basal conditions. When
the HNE cells from the controls were treated with IL-13
for 7 days, the anion channel activity was significantly
increased (0.23  0.17 DpH/min, P < 0.05), but not in
the epithelia from patients with SLC26A4 mutations
(0.18  0.06 DpH/min) (Fig. 5). The molecular and
functional data indicate that pendrin is a major anion
exchanger that responds to IL-13 and that the intracellu-
lar and ASL pH may be regulated by various anion
exchangers other than pendrin under basal conditions.
MUC5AC expression and goblet cell
differentiation
We also examined the role of pendrin in mucus secretion
in the airway epithelia. Quantitative real-time PCR data
showed that the expression of MUC5AC, a goblet cell
marker, was greatly increased by IL-13 treatment in cul-
tured cells from controls. In contrast, MUC5AC expres-
sion was comparatively low in cultured cells from DFNB4
patients, and it was not upregulated by IL-13 treatment
(Fig. 6A). Periodic acid-Schiff staining revealed goblet cell
hyperplasia in the control HNE cells following IL-13
treatment, but this was not observed in the epithelia from
DFNB4 subjects (Fig. 6B). Histologic examination of the
inferior turbinates also revealed that there was a much
lower number of PAS-positive cells (3.7  2.1/mm) in
the nasal mucosa from DFNB4 patients compared with
that from controls (10.3  3.7/mm) (Fig. 7).
Discussion
A recent report (Nakagami et al. 2008) indicates that pen-
drin is involved in the regulation of ASL thickness in
mice. Although the ASL thickness did not differ in
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Figure 6. MUC5AC expression and goblet cell differentiation in cultured human nasal epithelial cells. (A) Real-time PCR analysis showing
upregulation of MUC5AC by IL-13 (10 ng/ml) in controls (n = 3). In contrast, MUC5AC is weakly expressed and does not respond to IL-13 in
epithelia from patients carrying SLC26A4 mutations (DFNB4, n = 3). *indicates P < 0.05. (B) PAS staining showing goblet cell hyperplasia in
nasal epithelial cells from controls following IL-13 treatment (10 ng/mL) for 7 days, but not in epithelia from DFNB4 patients. Scale bar
represents 25 lm.
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Figure 7. PAS staining of inferior turbinates. (A) Representative images shows a much lower amount of PAS staining in turbinate tissue from
patients harboring SLC26A4 mutations (DFNB4) compared with the tissues from controls (bars indicate 200 lm) (B) Quantitative analysis of the
abundance of PAS-positive cells in 6 DFNB4 and 6 controls. *indicates P < 0.05.
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cultured tracheal epithelial cells between wild-type and
pendrin-deficient mice under basal conditions, the ASL
became much thicker in pendrin-deficient mice compared
to the cells from wild-type mice after stimulation with an
allergic cytokine (Nakagami et al. 2008). However,
pendrin regulates the pH of the ASL but has little effect
on fluid secretion in Calu-3 cells, which are human ser-
ous airway epithelial cells (Garnett et al. 2011). Therefore,
it was unclear whether pendrin regulates ASL volume in
airway epithelia in humans. In our data, the expression
pattern of ion transporters in airway epithelia was similar
between the patients with SLC26A4 mutations and con-
trols except for the weak expression of CFTR in patients
with SLC26A4 mutations. However, the ASL layer was
thicker in HNE cells from patients with SLC26A4 muta-
tions compared to controls. These data indicate that
pendrin is involved in ASL volume regulation even in
basal conditions. This finding is not consistent with data
from the mouse airway. This discrepancy may stem from
species differences in the role of ion transporters in air-
way epithelia. For instance, the expression patterns of ion
channels are quite different between mice and humans as
CFTR expression is barely detectable in mouse airway
epithelia. Another possible reason for the conflicting
results between reports may be attributable to a method-
ological problem. Nakagami et al. (2008) measured ASL
thickness 3 min after PBS/dye loading, before ASL thick-
ness had reached a steady state.
The mechanism by which pendrin regulates ASL is puz-
zling because this electroneutral transporter cannot gener-
ate an osmotic gradient. One possible mechanism
underlying this phenomenon is the evaporation of
A
B
Figure 8. The hypothetical role of pendrin in the regulation of airway surface liquid (ASL). (A) Pendrin regulates ASL volume via Cl and
subsequent water absorption. The secreted HCO3
 will evaporate, thus leading to net anion movement into the cells. Under inflammatory
conditions, upregulated pendrin compensates for the over-secreted fluid by upregulated ANO-1 channels. (B) In pendrin-deficient airways, ASL
thickness is increased due to the lack of Cl absorption by pendrin under basal conditions and cannot compensate for the over-accumulated fluid.
2015 | Vol. 3 | Iss. 8 | e12480
Page 8
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Airway Mucus Secretion in Pendrin Mutants H. J. Lee et al.
secreted HCO3
, which results in net anion movement
into the cell and subsequent Na+ absorption and genera-
tion of osmotic pressure for fluid absorption (Fig. 8A).
Interestingly, the difference of ASL height between normal
and pendrin-deficient airway epithelia became much more
prominent with IL-13 treatment. IL-13 induces airway
fluid secretion and as a result, the ASL thickness is
increased. In normal airway epithelial cells, the upregula-
tion of pendrin (~ 100 fold) following IL-13 treatment
compensates for the thickened ASL via Cl absorption.
However, presumably since this compensatory mechanism
does not exist in the pendrin mutants, it results in an
overaccumulation of ASL (Fig. 8B).
Pendrin seems to be not only involved in ASL regula-
tion, but also mucus secretion. Enforced expression of
pendrin in NCI-H292 cells or mouse airway epithelia
induces the upregulation of MUC5AC (Nakao et al.
2008). However, pendrin-deficient mice exhibit impaired
airway hyperresponsiveness and eosinophilic inflamma-
tion, but not mucus production. Our data showed that
MUC5AC was expressed at very low levels in the nasal
epithelia from SLC26A4 mutants and was not upregulated
by IL-13 treatment, which contrasts with our findings in
the cells of the controls. We also revealed that the goblet
cell differentiation in basal condition and hyperplasia
induced by IL-13 was minimal in the epithelia from
patients with SLC26A4 mutations. Furthermore, we
demonstrated that the proportion of goblet cells in the
nasal mucosa from patients with SLC26A4 mutation is
much lower compared to that in controls. These data all
together indicate that pendrin is a major participant in
mucous cell differentiation and hyperplasia induced by
allergic cytokines in airway epithelia. Although the exact
role of pendrin in mucus secretion in the airways epithe-
lia is unclear, pendrin may be involved in the infiltration
of Th2 inflammatory cells which produce several inflam-
matory mediators such as EGF and TNF-a. These media-
tors can regulate the transcription of the mucin gene via
activation of the transcription factors such as NF-j B, as
suggested by Rose & Voynow (Rose and Voynow 2006).
An interesting phenomenon is the linkage between the
pathogenesis of asthma and pendrin. Pendrin knockout
mice show less of an allergic response to OVA stimulation
than their wild-type counterparts (Nakagami et al. 2008).
Pendrin expression is upregulated after IL-4 stimulation in
cultured airway epithelia (Pedemonte et al. 2007) and dis-
ease tissues, such as those from asthma, COPD, and rhinitis
patients (Kuperman et al. 2005; Lewis et al. 2008; Ishida
et al. 2012). Moreover, patients with pendrin mutations
had a tendency to be resistant to asthma (Nakao et al.
2008). Based on our data, we postulate that the increase in
ASL thickness observed in the airways of pendrin-deficient
patients under basal conditions may decrease the chance of
allergens coming into contact with the airway epithelia, and
therefore hinder the initiation of allergic sensitization.
Moreover, the dramatic increase in ASL thickness induced
by allergic cytokines could further protect the airway
epithelia against exposure to allergens in pendrin-deficient
airways. Another possible mechanism explaining the lower
incidence of asthma in patients harboring pendrin muta-
tions is a defect in mucus secretion, although the exact
molecular mechanism underlying this process is unclear.
One limitation of our study is that we used cultured
nasal epithelia to represent the airways. Cultured nasal
epithelia are not ideal model for studying the pathogenesis
of asthma because the cellular phenotype and expression
pattern of ion transporters of nasal epithelia is somewhat
different from those of tracheobronchial epithelial cells.
However, following the guidelines of our institutional
review board, harvesting tracheobronchial cells from
patients undergoing ear surgery is too invasive of a proce-
dure, while it is much easier to obtain nasal mucosa.
The decreased expression of CFTR in DFNB4 patients
is an interesting finding. Our preliminary coimmunopre-
cipitating experiment shows that immune complexes of
airway epithelia lysate and CFTR antibody are clearly
reactive with the pendrin antibody, which suggests that
pendrin and CFTR may be coupled in chloride recycling.
The possible functional coupling of pendrin and CFTR
may become an important issue in the homeostasis of air-
way surface liquid. We need further experiments to inves-
tigate the exact mechanism of this coupling.
In summary, we showed that the ASL layer was
increased in human airway epithelial cells from patients
with SLC26A4 mutation compared to controls, and this
phenomenon was more prominent in allergic conditions.
Pendrin seems to be essential in mucin expression and
goblet cell development. These findings may explain the
low incidence of allergic airway diseases in patients with
SLC26A4 mutation. Specific blockers targeting pendrin in
the airway epithelium may represent promising candidate
drugs for the treatment of allergic airway diseases such as
asthma and allergic rhinitis.
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